Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousGraft vs Host DiseaseBone MarrowTransplantation ConditioningBone Marrow CellsHematopoietic Stem Cell MobilizationHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorHematologic NeoplasmsLeukapheresisBone and BonesGraft SurvivalStem CellsStem Cell TransplantationTreatment OutcomeWhole-Body IrradiationAntigens, CD34Tissue DonorsImmunosuppressive AgentsBusulfanCyclophosphamideBlood Component RemovalCombined Modality TherapyTransplantation ChimeraLeukemiaBone Marrow PurgingMelphalanAnemia, AplasticHistocompatibility TestingHistocompatibilityBone Marrow DiseasesHematopoiesisMultiple MyelomaRecurrenceAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinRemission InductionTime FactorsCord Blood Stem Cell TransplantationBlood CellsTransplantation, IsogeneicLeukemia, Myeloid, AcuteRetrospective StudiesCytomegalovirus InfectionsBlood Cell CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEtoposideColony-Forming Units AssayBone Marrow ExaminationSurvival AnalysisMyeloablative AgonistsBone RemodelingHematologic DiseasesLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaKidney TransplantationLeukocyte TransfusionSurvival RateFlow CytometryMice, Inbred C57BLCell DifferentiationDisease-Free SurvivalAcute DiseaseT-LymphocytesBone Marrow NeoplasmsMyelodysplastic SyndromesOpportunistic InfectionsImmunosuppressionInfectionLiver TransplantationCytarabineLeukemia, MyeloidThiotepaCyclosporineAntineoplastic Agents, AlkylatingCells, CulturedSalvage TherapyLeukocyte CountTransplantationHodgkin DiseaseTransplantation ImmunologyCell SeparationLymphomaImmunocompromised HostImmunophenotypingHLA AntigensFollow-Up StudiesPlatelet CountHepatic Veno-Occlusive DiseaseGraft RejectionCarmustineFatal OutcomeRadiation ChimeraGraft vs Leukemia EffectBlood DonorsBone Density